PMID- 33414143 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20210514 IS - 2044-6055 (Electronic) IS - 2044-6055 (Linking) VI - 11 IP - 1 DP - 2021 Jan 7 TI - Prevalence of comorbidities and their associated factors in patients with type 2 diabetes at a tertiary care department in Ningbo, China: a cross-sectional study. PG - e040532 LID - 10.1136/bmjopen-2020-040532 [doi] LID - e040532 AB - OBJECTIVES: To determine the prevalence of comorbidities in patients with type 2 diabetes mellitus (T2DM) and identify the factors independently associated with comorbidities in a tertiary care department in Ningbo, China. DESIGN: A computerised medical records database was used to conduct a cross-sectional study. SETTING: The study was conducted in a tertiary care department in Ningbo, China. PARTICIPANTS: The study was conducted on adult patients with T2DM, and it included 8 years of data, from 1 January 2012 to 31 December 2019. THE PRIMARY OUTCOME MEASURE: Comorbidity was defined as the coexistence of at least one other chronic condition, that is, either a physical non-communicable disease (duration >/=3 months), a mental health condition (duration >/=3 months) or an infectious disease (duration >/=3 months). RESULTS: In total, 4777 patients with T2DM satisfied the eligibility criteria. Over 8 years, the prevalence of comorbidities was 93.7%. The odds of comorbidities increased with the age of patients (18 to 39 years: 1; 40 to 59 years: OR 2.80, 95% CI 1.98 to 3.96; 60 to 69 years: OR 4.43, 95% CI 3.04 to 6.44; and >/=70 years: OR 10.97, 95% CI 7.17 to 16.77). The odds were lower in female patients (OR 0.66, 95% CI 0.51 to 0.84), patients residing in rural areas (OR 0.75, 95% CI 0.59 to 0.95) and patients without health insurance (OR 0.62, 95% CI 0.46 to 0.83). The odds were higher in single/divorced/widowed patients compared with those in married patients (OR 1.95, 95% CI 1.21 to 3.12). CONCLUSIONS: A large percentage of patients with T2DM in the tertiary care department in Ningbo, China, had comorbidities, and the factors associated with comorbidities were identified. The findings could be used in developing, evaluating and implementing interventions aimed at improving outcomes in patients with T2DM with comorbidities. CI - (c) Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. FAU - Li, Xueyu AU - Li X AD - School of Medicine, Ningbo University, Ningbo, China. AD - Department of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China. FAU - Chattopadhyay, Kaushik AU - Chattopadhyay K AUID- ORCID: 0000-0002-3235-8168 AD - Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK. FAU - Xu, Shengnan AU - Xu S AD - Department of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China. FAU - Chen, Yanshu AU - Chen Y AD - Department of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China. FAU - Xu, Miao AU - Xu M AD - Department of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China. FAU - Li, Li AU - Li L AUID- ORCID: 0000-0001-6301-3544 AD - Department of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China. FAU - Li, Jialin AU - Li J AUID- ORCID: 0000-0001-6930-9530 AD - Department of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China lijialin@sina.com. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210107 PL - England TA - BMJ Open JT - BMJ open JID - 101552874 SB - IM MH - Adolescent MH - Adult MH - China/epidemiology MH - Comorbidity MH - Cross-Sectional Studies MH - *Diabetes Mellitus, Type 2/epidemiology MH - Female MH - Humans MH - Prevalence MH - Tertiary Healthcare MH - Young Adult PMC - PMC7797259 OTO - NOTNLM OT - general diabetes OT - health services administration & management OT - public health COIS- Competing interests: None declared. EDAT- 2021/01/09 06:00 MHDA- 2021/05/15 06:00 PMCR- 2021/01/07 CRDT- 2021/01/08 06:00 PHST- 2021/01/08 06:00 [entrez] PHST- 2021/01/09 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] PHST- 2021/01/07 00:00 [pmc-release] AID - bmjopen-2020-040532 [pii] AID - 10.1136/bmjopen-2020-040532 [doi] PST - epublish SO - BMJ Open. 2021 Jan 7;11(1):e040532. doi: 10.1136/bmjopen-2020-040532.